Arbor Life Labs’ patented stem cell activation technology, via the Wnt/Beta-Catenin pathway and multi-targeting regenerative medicine platform, has a broad pipeline of natural therapeutics in an addressable market of $500 Billion via a non-drug regulatory pathway.